Lobby organisation
Orion Corporation
Business / industry · Health & pharma · HQ: Finland · Transparency Register entry
As of 9 September 2026, Orion Corporation appears in 7 declared MEP meetings (5 different MEPs), most often with Renew Europe.
In their own words
“Orion Pharma is a globally operating Finnish pharmaceutical company. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. The core therapy areas of our pharmaceutical R&D are oncology and pain. Orion Pharma builds well-being by bringing to markets drugs and therapies from which patients get help for their illnesses. Orion Pharma has around 4000 employees around…”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 7 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2023–2026. Bar length is relative to its busiest year (3 in 2026).
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 7 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 11 May 2026 | Katri Kulmuni | UWWTD-direktiivi |
| 8 May 2026 | Sebastian Tynkkynen | Yhdyskuntajätevesidirektiivi |
| 6 Mar 2026 | Katri Kulmuni | Biotech I |
| 6 Feb 2025 | Sirpa Pietikäinen | Critical Medicines |
| 20 Nov 2024 | Anna-Maja Henriksson | Trade policy |
| 16 Oct 2024 | Katri Kulmuni | Ajankohtaiset EU-lakihankkeet |
| 23 Oct 2023 | Ville Niinistö | Pharmaceutical legislation |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.